Nov 19, 2026
Nuropod has released a new guide exploring the connection between fibromyalgia and the vagus nerve, examining how the nervous system processes pain and why noninvasive vagus nerve stimulation is attracting growing research interest.
Sacramento, United States, November 19, 2026 /PressCable/ -- Nuropod has released a new guide examining the connection between the vagus nerve and fibromyalgia, including how pain signals are processed and why researchers are studying vagus nerve stimulation in relation to symptoms such as widespread pain and fatigue.
More information is available at https://nuropod.com/blogs/articles/vagus-nerve-and-fibromyalgia-pain-symptoms-connection
Fibromyalgia affects approximately 4 million adults in the United States, or around 2% of the adult population, the Centers for Disease Control and Prevention (CDC) reports. The condition can involve chronic widespread pain, fatigue, sleep disturbances, and cognitive difficulties, creating challenges that extend beyond physical discomfort alone.
The new guide explores these symptoms before examining why the vagus nerve has become an area of research interest. It explains that fibromyalgia is associated with changes in how the nervous system processes pain signals, rather than necessarily indicating tissue damage in the areas where pain is felt. The vagus nerve connects the brain with organs including the heart, lungs, and gut and contributes to autonomic regulation.
The guide also examines research involving Parasym's proprietary AVNT™ technology. Across studies involving different populations, the company reports an average 38% reduction in widespread pain and a 48% reduction in fatigue.
Nuropod uses the same proprietary AVNT waveform in a wearable device that delivers noninvasive vagus nerve stimulation through an earpiece attached to the tragus. The company describes typical sessions of around 30 minutes, once or twice daily, allowing users to incorporate the device into activities such as reading, working, or relaxing at home.
Parasym says its research program includes more than 60 completed clinical studies, 100+ ongoing studies, and collaborations with over 150 research institutions, supported by more than 10 years of research and development. Nuropod is intended for use alongside existing care rather than as a replacement for treatments recommended by healthcare professionals.
To learn more about Nuropod's vagus nerve stimulation technology and the research behind it, visit https://nuropod.com
Disclaimer: Research referenced in this article was conducted using Parasym’s neuromodulation technology under research conditions. Findings relate to specific study populations and should not be interpreted as guaranteed individual outcomes. Nuropod is classified by the FDA as a non-significant risk device and is not intended to diagnose, treat, cure, or prevent any disease.
Contact Info:
Name: PR Team
Email: Send Email
Organization: Nuropod by Parasym
Address: 2108 N Street, Sacramento, California 95816, United States
Website: https://nuropod.com/
Source: PressCable
Release ID: 89210080
In case of detection of errors, concerns, or irregularities in the content provided in this press release, or if there is a need for a press release takedown, we strongly encourage you to reach out promptly by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our efficient team will be at your disposal for immediate assistance within 8 hours – resolving identified issues diligently or guiding you through the removal process. We take great pride in delivering reliable and precise information to our valued readers.
The ruling by the International Court of Justice deals with issues relevant to the case brought against Israel alleging genocide in Gaza. Israel has rejected the charge.
President Trump called Russia’s leader his “friend” and marveled at China’s warm welcome for his first-ever trilateral summit. But there were no breakthroughs on nuclear control, the war in Ukraine or A.I.
Anthropic excluded investment firms from China and Hong Kong from buying shares in advance of its initial public offering.
President Claudia Sheinbaum flew commercial, a journey that involved a 15-hour leg. It was a symbol of her government’s commitment to austerity.
The United States, China and Russia agreed to boost the supply of refined petroleum products, as oil prices spike because of the Iran war.
After government troops and mobs rampaged through Rohingya communities in Myanmar in 2017, refugees fled to to Bangladesh.
Greenland’s politicians voted to change the Arctic island’s time zone to be farther from Denmark, its former colonial power, and closer to the United States.
People gathered in the rain to hear the ruling on whether Myanmar had committed genocide, though they understood it might not change their lives anytime soon.
Zammona’s erasure was part of a wider campaign of violence against Rohingya Muslims. An international court found that Myanmar was culpable for the atrocities.
Xi seems to have been a reluctant host who decided to turn the event to his own advantage.
Fresh violence broke out in Bangladesh on Thursday as former prime minister Sheikh Hasina’s supporters tried to bring businesses and public transport to a halt, with mixed success, and Prime Minister Tarique Rahman blamed India for the unrest. Unrelated protests by garment workers demanding higher wages also continued in some districts, with hundreds of workers blocking a highway into the capital Dhaka, forcing factories to close. The rising unrest in the Muslim-majority nation of 175 million...
After their summit, the leaders of Russia, the United States and China agreed that “a nuclear war cannot be won and must never be fought.” Some analysts are skeptical that real change will result.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.